Genome-scale CRISPR activation screening identifies a role of LRP8 in Sorafenib resistance in Hepatocellular carcinoma.
Cai J, Chen J, Wu T, Cheng Z, Tian Y, Pu C, Shi W, Suo X, Wu X, Zhang K. Biochem Biophys Res Commun. 2020 Jun 11; 526(4):1170-1176. Epub 2020 Apr 18.